ENTX · ISSUER CIK 1638097
Entera Bio Ltd.
Between Aug 1, 2026 and Oct 29, 2026, 5 Entera Bio Ltd. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 202616:23 | Aug 7, 2026 | ENTX | Director | A · Grant | — | +19,117 | 34,117 | +127% | — | ||
| Aug 7, 202616:22 | Aug 7, 2026 | ENTX | Director | A · Grant | — | +22,815 | 100,231 | +29% | — | ||
| Aug 7, 202616:22 | Aug 7, 2026 | ENTX | Director | A · Grant | — | +20,790 | 119,269 | +21% | — | ||
| Aug 7, 202616:21 | Aug 7, 2026 | ENTX | Director | A · Grant | — | +20,034 | 208,132 | +11% | — | ||
| Aug 7, 202616:18 | Aug 7, 2026 | ENTX | Director | A · Grant | — | +25,014 | 65,014 | +63% | — |